Pfizer Inc. (NYSE: PFE) Develops Antiviral Pill That Could Lower Demand for COVID-19 Vaccines

Pfizer Inc. (NYSE: PFE) announced that it had developed an antivirus pill causing the stocks of vaccine producers in Asia to fall. The antivirus pill known as Pexlovid is 89% effective in decreasing the risk of hospitalization or death from COVID-19 Shares for the Chinese vaccine maker, Cansino Biologics Inc (OTCMKTS: CASBF), dropped by 17% […]

Pfizer Inc. (NYSE:PFE) To Use Own Distribution Channel For COVID-19 Vaccines Instead Of Government Channel

Pfizer Inc. (NYSE:PFE) is planning to go alone to distribute the COVID-19 vaccine in the US once the FDA approves it instead of distributing it through the designated government coordinator.  Officials have questioned whether there is an adequate supply of medical-grade freezers in the US at the point of use for vaccines that need storages […]

Pfizer’s (NYSE:PFE) COVID-19 Trial in Children as Young as 12 Years Draws Mixed Sentiments

Pfizer Inc. (NYSE:PFE) recently announced an expansion to its COVID-19 vaccine trial to include teenagers and children of 12 years. The company is the first drugmaker to include children in their COVID-19 vaccine trials, and this has drawn divided reactions from different people. Pfizer testing vaccine in 3,000 teens The New York Pharms received approval […]